“…If the studied event is rare, such as de novo germline mutations, the likelihood to observe false positive (FP) calls is further increased (Gómez‐Romero et al., ; Veltman & Brunner, ). Moreover, rare variant association studies (RVAS) can generate false results if genes are enriched with sequencing or alignment errors, leading to false associations to the studied disease (Hou et al., ; Johnston, Hu, & Cutler, ; Yan et al., ). Hence, some RVAS methods take into account error probabilities (He et al., ) or bypass genotype calls completely by directly modeling sequencing reads (Hu, Liao, Johnston, Allen, & Satten, ).…”